Conclusion Of Non-exclusive Discount Agreements In Accordance With §§ 130a Para. 8/130c Abs. 1 Sgb V On Drugs With The Active Ingredient Imiquimod (d06bb10) As Part Of A So-called Open-house Model.

AOK RHEINLAND-PFALZ SAARLAND - DIE GESUNDHEITSKASSE Germany has Released a tender for Conclusion Of Non-exclusive Discount Agreements In Accordance With §§ 130a Para. 8/130c Abs. 1 Sgb V On Drugs With The Active Ingredient Imiquimod (d06bb10) As Part Of A So-called Open-house Model. in Pharmaceuticals. The tender was released on Sep 22, 2022.

Country - Germany

Summary - Conclusion Of Non-exclusive Discount Agreements In Accordance With §§ 130a Para. 8/130c Abs. 1 Sgb V On Drugs With The Active Ingredient Imiquimod (d06bb10) As Part Of A So-called Open-house Model.

Deadline - login to view

MT reference number - 10741480

Product classification - Injectable solutions

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 10741480

  Document Type - Tender Notices

Notice Details and Documents:

Description - Contract notice: Conclusion of non-exclusive discount agreements in accordance with §§ 130a para. 8/130c abs. 1 sgb v on drugs with the active ingredient imiquimod (d06bb10) as part of a so-called open-house model.Conclusion of non-exclusive discou nt agreements in accordance with §§ 130a para. 8/130c abs. 1 sgb v for medicinal products with the active ingredient imiquimod (d06bb10) within the period from 11/01/2022 to 10/31/2024 with the possibility of concluding a contract at any time (open-house model).The AOK Rhineland-Palatinate/Saarland - the health insurance fund offers all interested pharmaceutical companies discount contracts with the active substance imiquimod (d06bb10) without

Mt Ref Id - 10741480

Deadline - Aug 31, 2024

Share

Similar Tenders :